Table 2 Measurements of lesions by mRECIST & vRECIST both before and after TACE and percentage of tumour change
Mean | Standard deviation | Median | Minimum | Maximum | |
|---|---|---|---|---|---|
Pre mRECIST | 5.36 | 3.06 | 4.80 | 1.50 | 13.60 |
Post mRECIST | 3.98 | 2.62 | 3.32 | .00 | 11.80 |
% (Tc) mRECIST | .28 | .25 | .25 | − .35- | 1.00 |
Pre vRECIST | 96.76 | 141.67 | 52.90 | 2.90 | 570.00 |
Post vRECIST | 97.56 | 143.46 | 53.40 | 2.90 | 593.00 |
Viable post vRECIST | 34.56 | 53.79 | 13.25 | .00 | 292.00 |
% (Tc) vRECIST | .66 | .24 | .69 | − .24- | 1.00 |